Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance.
Whitehead CE, Ziemke EK, Frankowski-McGregor CL, Mumby RA, Chung J, Li J, Osher N, Coker O, Baladandayuthapani V, Kopetz S, Sebolt-Leopold JS. Whitehead CE, et al. Among authors: baladandayuthapani v. Nat Cancer. 2024 Aug;5(8):1250-1266. doi: 10.1038/s43018-024-00781-6. Epub 2024 Jul 11. Nat Cancer. 2024. PMID: 38992135 Free PMC article.
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial.
Nguyen CB, Reimers MA, Perera C, Abida W, Chou J, Feng FY, Antonarakis ES, McKay RR, Pachynski RK, Zhang J, Reichert ZR, Palmbos PL, Caram MEV, Vaishampayan UN, Heath EI, Hopkins AC, Cieslik MP, Wu YM, Robinson DR, Baladandayuthapani V, Chinnaiyan AM, Alva AS. Nguyen CB, et al. Among authors: baladandayuthapani v. Clin Cancer Res. 2024 Aug 1;30(15):3200-3210. doi: 10.1158/1078-0432.CCR-24-0400. Clin Cancer Res. 2024. PMID: 38787530 Clinical Trial.
Tumor radiogenomics in gliomas with Bayesian layered variable selection.
Mohammed S, Kurtek S, Bharath K, Rao A, Baladandayuthapani V. Mohammed S, et al. Among authors: baladandayuthapani v. Med Image Anal. 2023 Dec;90:102964. doi: 10.1016/j.media.2023.102964. Epub 2023 Sep 12. Med Image Anal. 2023. PMID: 37797481 Free article.
PROBABILISTIC LEARNING OF TREATMENT TREES IN CANCER.
Yao TH, Wu Z, Bharath K, Li J, Baladandayuthapani V. Yao TH, et al. Among authors: baladandayuthapani v. Ann Appl Stat. 2023 Sep;17(3):1884-1908. doi: 10.1214/22-aoas1696. Epub 2023 Sep 7. Ann Appl Stat. 2023. PMID: 37711665 Free PMC article.
DIMPLE: AN R PACKAGE TO QUANTIFY, VISUALIZE, AND MODEL SPATIAL CELLULAR INTERACTIONS FROM MULTIPLEX IMAGING WITH DISTANCE MATRICES.
Masotti M, Osher N, Eliason J, Rao A, Baladandayuthapani V. Masotti M, et al. Among authors: baladandayuthapani v. bioRxiv [Preprint]. 2023 Jul 22:2023.07.20.548170. doi: 10.1101/2023.07.20.548170. bioRxiv. 2023. Update in: Patterns (N Y). 2023 Nov 20;4(12):100879. doi: 10.1016/j.patter.2023.100879 PMID: 37503048 Free PMC article. Updated. Preprint.
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment.
Morikawa A, Li J, Ulintz P, Cheng X, Apfel A, Robinson D, Hopkins A, Kumar-Sinha C, Wu YM, Serhan H, Verbal K, Thomas D, Hayes DF, Chinnaiyan AM, Baladandayuthapani V, Heth J, Soellner MB, Merajver SD, Merrill N. Morikawa A, et al. Among authors: baladandayuthapani v. Cancer Res Commun. 2023 Jun 21;3(6):1093-1103. doi: 10.1158/2767-9764.CRC-22-0492. eCollection 2023 Jun. Cancer Res Commun. 2023. PMID: 37377606 Free PMC article.
142 results